소화관 스텐트 시장 규모, 점유율, 성장 분석 : 제품별, 재료별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)

Global Gastrointestinal Stents Market size was valued at USD 443.2 million in 2022 and is poised to grow from USD 467.13 million in 2023 to USD 711.48 million by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

The global gastrointestinal stents market is witnessing robust growth, fueled by the escalating prevalence of gastrointestinal disorders and an aging population. Lifestyle changes, poor dietary habits, and rising obesity rates have led to an increase in conditions such as colorectal cancer and inflammatory bowel diseases. Consequently, the demand for gastrointestinal stents is on the rise, as they provide effective, less invasive treatment alternatives that enhance patient quality of life. The market is further bolstered by the elderly demographic, which is more susceptible to age-related gastrointestinal issues, fostering a preference for minimally invasive options like stents. Innovations such as self-expandable metal stents (SEMS) and biodegradable variants are transforming the landscape, offering improved outcomes and patient comfort, thereby driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gastrointestinal Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gastrointestinal Stents Market Segmental Analysis

Global Gastrointestinal Stents Market is segmented by products, material, application, end users and region. Based on products, the market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents and esophageal stents. Based on material, the market is segmented into self-expanding metal stents, nitinol, plastic stents and others. Based on application, the market is segmented into biliary diseases, irritable bowel syndrome, gastrointestinal cancers, colorectal cancer, stomach cancer, esophageal cancer and pancreatic cancer. Based on end users, the market is segmented into hospitals and clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gastrointestinal Stents Market

The Global Gastrointestinal Stents market is significantly driven by heightened awareness among patients and healthcare providers regarding the advantages of gastrointestinal stenting. This increased knowledge facilitates earlier diagnoses and timely medical interventions, which are crucial for effective treatment. Additionally, advancements in healthcare access, particularly in developing regions, have led to a rise in the adoption of stenting procedures. As more individuals gain access to quality healthcare services and understand the effectiveness of these stents, the overall demand in the market continues to grow, contributing to its ongoing expansion and evolution.

Restraints in the Global Gastrointestinal Stents Market

One significant restraint affecting the Global Gastrointestinal Stents market is the presence of limited reimbursement policies in certain regions. These policies can impose strict criteria on procedures involving gastrointestinal stents, which can significantly impact the affordability and accessibility of these treatments for patients. As a result, the financial burden on healthcare providers and patients can restrict the adoption of stent-based therapies, ultimately obstructing the overall growth and development of the market. Consequently, these reimbursement challenges may deter healthcare practitioners from recommending stent procedures, further limiting the potential market expansion.

Market Trends of the Global Gastrointestinal Stents Market

The global gastrointestinal stents market is witnessing a notable trend towards the adoption of biodegradable stents, driven by their clear advantages over traditional metallic alternatives. These innovative stents are designed to dissolve gradually, eliminating the need for invasive removal procedures, thus enhancing patient convenience and safety. As healthcare providers increasingly emphasize patient-centered care, the demand for biodegradable options is growing, reflecting a shift towards more effective and less invasive treatment methodologies. Additionally, biodegradable stents support the healing process by providing temporary structural integrity, making them a preferred choice for both clinicians and patients. This trend signifies a transformative phase within the gastrointestinal stent market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Gastrointestinal Stents Market Size by Products & CAGR (2024-2031)

• Market Overview
• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

Global Gastrointestinal Stents Market Size by Material & CAGR (2024-2031)

• Market Overview
• Self-Expanding Metal Stents
• Nitinol
• Plastic Stents
• Others

Global Gastrointestinal Stents Market Size by Application & CAGR (2024-2031)

• Market Overview
• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers
• Colorectal Cancer
• Stomach Cancer
• Esophageal Cancer
• Pancreatic Cancer

Global Gastrointestinal Stents Market Size by End Users & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centers

Global Gastrointestinal Stents Market Size & CAGR (2024-2031)

• North America (Products, Material, Application, End Users)
  • USA
  • Canada
• Europe (Products, Material, Application, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Products, Material, Application, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Products, Material, Application, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products, Material, Application, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELLA-CS s.r.o. (Czech Republic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hobbs Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taewoong Medical Co. Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S&G Biotech Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations